Lindbrook Capital’s Insulet PODD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
$88.5K Buy
337
+46
+16% +$12.4K 0.01% 726
2024
Q4
$76K Buy
291
+1
+0.3% +$252 0.01% 645
2024
Q3
$67.5K Buy
290
+23
+9% +$4.72K 0.01% 693
2024
Q2
$53.9K Buy
267
+102
+62% +$18.4K 0.01% 758
2024
Q1
$28.3K Sell
165
-27
-14% -$5.04K ﹤0.01% 1038
2023
Q4
$41.7K Buy
192
+75
+64% +$12.9K ﹤0.01% 824
2023
Q3
$18.7K Buy
117
+52
+80% +$11.6K ﹤0.01% 1088
2023
Q2
$18.7K Sell
65
-49
-43% -$14.9K ﹤0.01% 1132
2023
Q1
$36.4K Buy
114
+50
+78% +$14.8K ﹤0.01% 820
2022
Q4
$18.8K Buy
64
+45
+237% +$12.4K ﹤0.01% 1087
2022
Q3
$4K Buy
19
+1
+6% +$250 ﹤0.01% 1785
2022
Q2
$4K Buy
18
+2
+13% +$455 ﹤0.01% 1676
2022
Q1
$4K Sell
16
-3
-16% -$736 ﹤0.01% 1733
2021
Q4
$5K Sell
19
-3
-14% -$870 ﹤0.01% 1522
2021
Q3
$6K Sell
22
-25
-53% -$7.13K ﹤0.01% 1207
2021
Q2
$13K Sell
47
-22
-32% -$5.98K ﹤0.01% 950
2021
Q1
$18K Buy
69
+30
+77% +$8.03K ﹤0.01% 784
2020
Q4
$10K Buy
39
+7
+22% +$1.74K ﹤0.01% 917
2020
Q3
$8K Buy
32
+15
+88% +$3.16K ﹤0.01% 925
2020
Q2
$3K Buy
17
+6
+55% +$1.15K ﹤0.01% 1289
2020
Q1
$2K Buy
+11
New +$2.01K ﹤0.01% 1327

Other funds holding PODD

Lindbrook Capital's PODD Position: Q1 2025 in Review

Lindbrook Capital increased its Insulet (PODD) stake by 16% in Q1 2025, buying an estimated $12.4K and bringing the position to 337 shares worth $88.5K. The position accounts for 0.01% of the portfolio, ranked #726.

Lindbrook Capital first reported a position in PODD in Q1 2020 and has held it in 21 quarters since. 718 funds tracked by Wall St. Rank hold PODD as of Q1 2025.

  • Lindbrook Capital held 337 shares of Insulet worth $88.5K as of Q1 2025.
  • Lindbrook Capital bought 46 Insulet shares in Q1 2025, an estimated $12.4K.
  • Insulet made up 0.01% of Lindbrook Capital's portfolio in Q1 2025, its #726 holding.
  • Lindbrook Capital first reported a position in Insulet in Q1 2020 and has held it in 21 quarters since.
  • 718 funds tracked by Wall St. Rank held Insulet as of Q1 2025.

Based on Lindbrook Capital's 13F filing for Q1 2025, filed 5 May 2025.